Home » Newsletters » BioWorld Asia

BioWorld Asia

Dec. 13, 2000

View Archived Issues

Tibotec Raises $36.5M Privately In Third Round For HIV Drugs

New Antigen-Delivery Method Could Boost Cancer Therapies

Genmab, Gemini Enter Broad Antibody Therapeutics Alliance

Other News To Note

EU Continues Effort To Balance Risks, Benefits Of Biotechnology

Existing Venture Investors Give Another #13M To Adprotech

Diversys Founded On Technology From Winter II Antibody Patents

Neurotech Shows ECT Works In Animals, Eyes Human Tests

German Company Arcensus Developing Pathogen Chips

Liponex Formed On Cholesterol Work From Ottawa Heart Institute

Compugen Expands Presence Through Office In California

Prodi Wants To Strengthen Ethics Advisory Group's Role

Immunobiology Raises Seed Funding For HSP Technology

bi12132000n.html

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...